When Lauren Otsuki and Vimla Black-Gupta launched skin-care brand Ourself in February 2022, their main goal was to provide beauty consumers with cosmetic enhancement options other than injections and lasers. To date, the indie brand has received $30 million in funding for its groundbreaking, at-home biotech alternatives to clinical products. 
Ourself's science-backed products are said to give the same effects as fillers and toxins. The company's ability to leverage science has helped it gain a large following in less than a year. Currently, the brand has 23 products, with some standouts being a two-step lip filler alternative and a five-product hyperpigmentation healer. 
"The idea of Ourself was about looking like yourself — because when did that actually stop being OK? The second meaning of Ourself is that you actually do it yourself," Black-Gupta said on the latest episode of The Glossy Beauty Podcast. "What our technology offers for the first time ever is to be able to get visible results that are self-administered from the comfort of your home. It's easy to use, and you get visible results."
Co-founders Otsuki and Black-Gupta have long careers in the beauty industry. Otsuki previously founded five biotech firms, including SkinMedica and Alastin Skincare, and is the evp of Glo Pharma, Ourself's parent company. Black-Gupta was formerly CMO of Equinox and also held marketing roles at Estée Lauder, P&G and Bobby Brown.
The duo is confident Ourself will revolutionize topical skin care. And as the brand prepares to celebrate its first anniversary, Otsuki and Black-Gupta are working to strengthen its DTC channels to ensure longevity.